50 results
Summary of Recommendations for the Treatment of Aspergillosis - IDSA Guidelines
 - Invasive syndromes of Aspergillus
Aspergillosis - IDSA ... Guidelines - ... Aspergillosis #Treatment #pharmacology ... #dosing #medications ... #IDSA #Guidelines
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
Tuberculosis - IDSA ... Guidelines # ... Therapy #regimens #medications ... #pharmacology # ... IDSA #Guidelines
Guidelines for Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip
Guidelines for Perioperative ... Antirheumatic Medication ... #rheumatology #medications ... perioperative #guidelines ... management #autoimmune #pharmacology
Oral Antihypertensive Medications - Selection by Comorbidities
Comorbidities: 
 • Stable Angina, HFpEF, HFrEF, AFib, TAA/Marfan, Aortic
Antihypertensive Medications ... Stable Angina, HFpEF ... , HFrEF, AFib, TAA ... Antihypertensive #Medications ... Comorbidities #pharmacology
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
), we follow Guideline-Directed ... getting patients on medication ... both of these medications ... by the ACC/AHA guidelines ... #Pharmacology #
HFrEF: Guideline Directed Medical Therapy

"Must Be On"
 • ACEI, ARB, or ARNI AND select Beta Blockers
HFrEF: Guideline ... American patients #hfref ... #management #medications
Asymptomatic Bacteriuria - IDSA Indications for Treatment
Healthy non-pregnant women - NO
Healthy pregnant women - YES
Functionally impaired
Bacteriuria - IDSA ... Indications for ... www.idsociety.org/practice-guideline ... #Bacteriuria #IDSA ... #Indications #Treatment
COVID-19: ICU Guidelines for the Non-Intensivist
Infection Control
Risk Factors for Severe Disease
Initial Laboratory Workup
COVID-19 Specific Medications
Respiratory
Cardiac
Hematologic
Neuro/Sedation

#COVID19 #ICU
COVID-19: ICU Guidelines ... COVID-19 Specific Medications ... #criticalcare #Guidelines
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Inhibitor GOLD 2019 Guideline ... 2019 COPD GOLD guidelines ... exacerbations. 2019 GOLD guidelines ... #Roflumilast #Indications ... #Pharmacology #
Guideline-Directed Medical Therapy (GDMT) in HFrEF and CKD

 • Class I pillars of HFrEF GDMT across
Guideline-Directed ... Therapy (GDMT) in HFrEF ... Chronotropes • Medications ... Jiawei Tan, MD #Guideline ... #management #pharmacology